Congress
$1,001–$15,000
Traded Nov 3, 2025 · disclosed 38 days laterJoint
Held by the filer's joint per the disclosure.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Nov 18, 2025 · Filed Nov 20, 2025
Quest Diagnostics's SVP & Chief Commercial Officer sold $1.49M of Quest Diagnostics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$1,488,683
Shares × reported transaction price
28 days after results of Oct 21, 2025, 55 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $185.32 on Nov 18, 2025, within 3% of its 52-week high, after a 2% rise over the previous 30 trading days
52-week range $150.33 (Jan 15, 2025) to $190.58 (Sep 30, 2025), 87% of the way up, from 250 adjusted closes. 30 trading days earlier: $181.89 on Oct 7, 2025. Describes the past only, not a forecast
RSI 55, 6% above its 200-day average, 1% above its 50-day average, 3% below the 52-week high, 20-day volatility 21% a year, against the S&P 500: −1 points over 1 month, −3 points over 3 months, −7 points over 6 months
From the adjusted closes up to Nov 18, 2025. RSI: Wilder's 14-day relative strength index (0 to 100). Averages: the last 50 and 200 closes. Volatility: standard deviation of the last 20 daily returns, annualised. S&P 500: the stock's move minus SPY's between the same dates (21, 63 and 126 trading days). Describes the past only, not a forecast
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
Mark E Delaney's largest sale of DGX in their filings since 2024
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −1.1% | +3.7% | −4.8% |
| 30 days | −7.8% | +3.9% | −11.7% |
| 90 days | +5.8% | +3.9% | +2.0% |
| 180 days | +1.3% | +12.5% | −11.2% |
Past results only. Not a forecast.
Congress
Traded Nov 3, 2025 · disclosed 38 days laterJoint
Held by the filer's joint per the disclosure.
Insider selling
Traded Nov 25, 2025 · filed 3 days laterNot reported under a pre-arranged trading plan
A Quest Diagnostics director sold $240K of Quest Diagnostics shares. The filing does not indicate a pre-arranged trading plan.
Insider filing
Traded Nov 25, 2025 · filed 3 days later
Derivative exercise or conversion — not an open-market buy.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.